LAVA Medtech Acquisition ... (LVACU)
10.40
0.00 (0.00%)
At close: Apr 19, 2023, 3:46 PM
Company Description
LAVA Medtech Acquisition Corp. does not have significant operations.
It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
The company focuses on pursuing opportunities in healthcare and healthcare-related industries.
The company was incorporated in 2021 and is based in Waltham, Massachusetts.
LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP.
LAVA Medtech Acquisition Corp.

Country | United States |
IPO Date | Oct 27, 2021 |
Industry | Shell Companies |
Sector | Financial Services |
Employees | n/a |
CEO | Dr. Anthony Natale M.B.A., M.D. |
Contact Details
Address: 303 Wyman Street Waltham, Massachusetts United States | |
Website | n/a |
Stock Details
Ticker Symbol | LVACU |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001855450 |
CUSIP Number | n/a |
ISIN Number | n/a |
Employer ID | 86-2973712 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Dr. Anthony Natale M.B.A., M.D. | Chief Executive Officer & Director |
Vasco Larcina C.A., C.P.A., CPA | Chief Financial Officer |
Vasco Larcina C.A., CPA | Chief Financial Officer |
Vasco Larcina C.A., CPA, CPA | Chief Financial Officer |
Dr. Jean Daniel Hetu M.B.A., M.D., MBA | Executive Vice President |
Gerald A. Brunk M.B.A. | Pres & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 09, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Jan 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
May 15, 2023 | 15-12G | Filing |
May 12, 2023 | 25-NSE | Filing |
May 10, 2023 | 8-K | Current Report |
May 01, 2023 | 8-K | Current Report |
Apr 18, 2023 | 8-K | Current Report |
Apr 10, 2023 | DEF 14A | Filing |
Mar 30, 2023 | 10-K | Annual Report |
Mar 27, 2023 | PRE 14A | Filing |